TEST:

CervicaDx

"MGI...today announced a collaboration with Predica Diagnostics, a leading innovator in oncology diagnostics, to develop Predica’s targeted RNA sequencing tests on MGI’s cost-effective next-generation sequencing platforms....The collaboration aims to revolutionize molecular diagnostics by enabling early detection of cancer and facilitating personalized targeted treatment strategies. By combining Predica Diagnostics’ advanced sequencing assays with MGI’s cutting-edge next-generation sequencing platforms, the initiative promises a fast, accurate and affordable solution for healthcare providers."